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Blindness From Quinine Toxicity 
S Lewallen, L Bandawe, B Wills 
Treatment of febrile children with antimalarials with little 
or no investigation is standard practice in many areas . 
Since January 1993 sulfadoxine-pyrimethamine has been 
the recommended first line treatment for children in 
Malawi in whom malaria is suspected. The Ministry of 
Health (MOH) recommends that parenteral quinine be 
reserved for children ' with severe malaria; that is, those 
with altered consciousness, repeated convulsions, persist-
ent vomiting precluding oral treatment, or very severe 
anaemia. Whenever possible, the diagnosis should be 
confirmed by blood film examination. Oral quinine is 
recommended for children who are allergic to sulfa drugs 
and for those with documented parasitaemia who shm'l 
no improvement after appropriate treatment with sul-
fadoxine-pyrimethamine. The malaria treatment guide-
lines also emphasize the importance of considering 
alternative diagnoses in febrile children. The indiscrimi-
nate use of quinine should be discouraged and health 
workers should be aware of the potential hazards of 
quinine toxicity, particularly in small children. The fol-
lowing case illustrates this point. 
The patient, a 15 month old male, presented with 
spasticity of all limbs for 2-3 weeks. The patient was the 
product of a normal delivery and was well for the first 
month of life, but started having convulsions 3-4 times a 
week after that. His mother thought he was afebrile 
during this time. He was taken to a rural hospital where 
he was treated with intravenous quinine and diazepam, 
followed by oral quinine on discharge. Over the next 8 
months the patient experienced recurrent fevers, devel-
oped diarrhoea, and started losing weight. During these 
8 months he was treated with 2-3 day courses of oral 
quinine every few weeks, according to the mother, for 
recurrent fevers . When the child was one year old a 
radiologic diagnosis of pulmonary TB was made and he 
began treatment with Streptomycin and HTI. Two 
months later the patient was given a blood transfusion 
"for pallor" and about a week later the mother noted that 
the child was not seeing properly, had stopped walking 
and talking, and had developed stiff limbs. At this point 
she brought the child to QECH. 
Physical examination revealed a severely wasted child 
with axillary and cervical lymphadenopathy. Hyperre-
flexia and hypertonia were present in all limbs. The child 
was poorly responsive to stimulation and appeared to be 
blind. The right pupil did not react to light, and the left 
reacted only slightly. Fundus exam showed marked atro-
phy of both optic nerves, the right being chalk white. 
Retinal blood vessels were completely constricted and 
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sheathed, appearing as thin white threads against the 
dark background of an atrophied retina. There were a 
few vessels still patent on the left optic nerve, consistent 
with the minimal pupil reaction and colour of the nerve. 
Investigations showed haemoglobin 8.7 and white 
blood count 3.5 (normal differential). Lumbar puncture 
yielded clear CSF which was negative on culture; Gram, 
india ink, and acid fast bacilli stains were all negative. 
The mother requested discharge fr?m hospital before 
any furtller investigations could be carried out. 
Paediatricians consulted considered the diagnosis in 
this case to be most consistent with AIDS related complex 
(ARC). The ophthalmologic findings are those of bilat-
eral central retinal artery obstruction , consistent with the 
late picture of quinine toxicity. 
DISCUSSION 
The pathogenesis of blindness in qUllllne tOXICity re-
mains a controvel'sial subject, particularly in the acute 
stages. Controversy centres on the relative contributions of 
retinal hypoxia secondalY to vasospasm versus toxic damage 
directly to tlIe retina.' Some patients with blindness and 
acute quinine ovel'dose present with normal fundi and 
recover visioll after a few days. Others present with arteri-
olar spasm, venous dilatation, and retinal edema. The 
classic late picture of quinine toxicity, however, is that of an 
old central retinal artelY obstruction, i.e. retinal vessel 
constriction and sheathing with diffuse retinal atrophy and 
optic nerve atrophy. In an adult such a finding is generally 
associated with systemic vascular disease (such as hyperten-
sion or diabetes) and is bilateral in less than 5 % of cases. 
There are no common causes of this phenomenon in 
children. Specifically, such fundus changes have not been 
associated with AIDS or ARC. 
It is possible for exogenous substances (e.g. talc, corn-
starch, or other impurities in intravenous injections) to 
cause embolic obstlUction of the central retinal artery. 
Neurologic examination was quite abnormal in this child 
and the possibility of multiple emboli to the brain and retina 
cannot be ruled Ollt, particularly in light of the history of a 
blood transfusion shortly before the mother noted blind-
ness. The retinal findings in this child, however, would have 
required several weeks or months to develop. In view of the 
histOlY of frequent doses of quinine, we believe that quinine 
toxicity was the cause of blindness. We have seen several 
other cases at QECH with an identical fundus picture and 
histOlY of quinille use . 
Quinine is a useful drug, but can have serious toxicity. 
It should be give n according to MOH guidelines and 
should not be used to treat recurrent fevers in children 
such as the one described here. 
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